Variant report
Variant | esv2569672 |
---|---|
Chromosome Location | chr5:147460908-147462821 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:147449509..147451055-chr5:147462616..147464573,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528910980 | chr5:147460937-147460938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191144468 | chr5:147460949-147460950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550591422 | chr5:147460971-147460972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562304416 | chr5:147461013-147461014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs180962210 | chr5:147461050-147461051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548278006 | chr5:147461119-147461120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186131940 | chr5:147461131-147461132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142648796 | chr5:147461136-147461137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534011099 | chr5:147461172-147461173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552062660 | chr5:147461224-147461225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190936221 | chr5:147461252-147461253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537712253 | chr5:147461258-147461259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs75944305 | chr5:147461287-147461288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182732163 | chr5:147461289-147461290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141046207 | chr5:147461292-147461293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553884106 | chr5:147461371-147461372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572187508 | chr5:147461400-147461401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35711826 | chr5:147461410-147461411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376042982 | chr5:147461444-147461445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187496273 | chr5:147461461-147461462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114950963 | chr5:147461606-147461607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs150257389 | chr5:147461631-147461632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191107954 | chr5:147461724-147461725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76687076 | chr5:147461731-147461732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs398084544 | chr5:147461733-147461734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568263578 | chr5:147461746-147461747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562487942 | chr5:147461770-147461771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11950479 | chr5:147461778-147461779 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs183372746 | chr5:147461781-147461782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371640670 | chr5:147461860-147461861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs10213857 | chr5:147461864-147461865 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs369206564 | chr5:147461942-147461943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527390035 | chr5:147462132-147462133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552387209 | chr5:147462146-147462147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138952198 | chr5:147462150-147462151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552810616 | chr5:147462374-147462375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188062314 | chr5:147462514-147462515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566186271 | chr5:147462546-147462547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142153164 | chr5:147462547-147462548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192582746 | chr5:147462560-147462561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10059850 | chr5:147462582-147462583 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs10065129 | chr5:147462637-147462638 | Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Hyperekplexia | 16941485 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Crohn''s disease | 20877625 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:147437800-147463800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr5:147450400-147469000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr5:147450600-147468600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr5:147450800-147474000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr5:147451000-147470000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
6 | chr5:147454000-147470000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr5:147455600-147469000 | Weak transcription | Esophagus | oesophagus |
8 | chr5:147457600-147462600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr5:147462600-147463200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr5:147462600-147471600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |